Check the vial, not the box
What happens to traceability when bulk material is subdivided, repackaged and relabelled two or three times before sale.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 22 of 48 of this archive, newest first.
What happens to traceability when bulk material is subdivided, repackaged and relabelled two or three times before sale.
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
Follow the resin, not the catalogue.
Follow the resin, not the catalogue.
The route did not close because of a rule about peptides.
A badge asserts that something was tested. It does not assert what, when, on whose sample, by what method, or whether the lot on sale is the lot that was tested.
The route did not close because of a rule about peptides.
Follow the resin, not the catalogue.
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
A result on one vial generalises to a batch only if the vial was drawn in a way that makes it representative — and nobody records how it was drawn.
Follow the resin, not the catalogue.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The result is unremarkable. What the report omits is not.
The route did not close because of a rule about peptides.
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
The route did not close because of a rule about peptides.
Follow the resin, not the catalogue.
The route did not close because of a rule about peptides.
Follow the resin, not the catalogue.